about
The human-bacterial pathogen protein interaction networks of Bacillus anthracis, Francisella tularensis, and Yersinia pestisAbscisic acid regulates inflammation via ligand-binding domain-independent activation of peroxisome proliferator-activated receptor gammaModeling-Enabled Systems Nutritional ImmunologyNutritional protective mechanisms against gut inflammationDietary α-eleostearic acid ameliorates experimental inflammatory bowel disease in mice by activating peroxisome proliferator-activated receptor-γComputational modeling-based discovery of novel classes of anti-inflammatory drugs that target lanthionine synthetase C-like protein 2Modeling-Enabled Characterization of Novel NLRX1 LigandsGoals in Nutrition Science 2015-2020Immunoregulatory mechanisms underlying prevention of colitis-associated colorectal cancer by probiotic bacteriaZinc deficiency alters host response and pathogen virulence in a mouse model of enteroaggregative Escherichia coli-induced diarrhea.Preclinical studies of amixicile, a systemic therapeutic developed for treatment of Clostridium difficile infections that also shows efficacy against Helicobacter pyloriEnteroaggregative Escherichia coli strain in a novel weaned mouse model: exacerbation by malnutrition, biofilm as a virulence factor and treatment by nitazoxanide.Mutations to essential orphan response regulator HP1043 of Helicobacter pylori result in growth-stage regulatory defects.The role of peroxisome proliferator-activated receptor γ in immune responses to enteroaggregative Escherichia coli infection.Modeling the role of peroxisome proliferator-activated receptor γ and microRNA-146 in mucosal immune responses to Clostridium difficile.Putting the pieces of the puzzle together - a series of hypotheses on the etiology and pathogenesis of type 1 diabetes.Virtual Screening as a Technique for PPAR Modulator Discovery.Modulation of hepatic PPAR expression during Ft LVS LPS-induced protection from Francisella tularensis LVS infection.Immunoregulatory actions of epithelial cell PPAR gamma at the colonic mucosa of mice with experimental inflammatory bowel disease.Molecular modeling of lanthionine synthetase component C-like protein 2: a potential target for the discovery of novel type 2 diabetes prophylactics and therapeutics.The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease.Conjugated linoleic acid ameliorates inflammation-induced colorectal cancer in mice through activation of PPARgamma.Gene regulatory network reveals oxidative stress as the underlying molecular mechanism of type 2 diabetes and hypertension.Abscisic Acid: A Novel Nutraceutical for Glycemic Control.Green tea extract decreases muscle pathology and NF-kappaB immunostaining in regenerating muscle fibers of mdx mice.Abscisic acid synergizes with rosiglitazone to improve glucose tolerance and down-modulate macrophage accumulation in adipose tissue: possible action of the cAMP/PKA/PPAR γ axis.Abscisic acid ameliorates atherosclerosis by suppressing macrophage and CD4+ T cell recruitment into the aortic wallAbscisic acid ameliorates experimental IBD by downregulating cellular adhesion molecule expression and suppressing immune cell infiltration.Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in miceSystems modeling of the role of interleukin-21 in the maintenance of effector CD4+ T cell responses during chronic Helicobacter pylori infection.Nutritional regulation of porcine bacterial-induced colitis by conjugated linoleic acid.Probiotic bacteria produce conjugated linoleic acid locally in the gut that targets macrophage PPAR γ to suppress colitisConjugated linoleic acid ameliorates viral infectivity in a pig model of virally induced immunosuppression.Immunomodulatory properties of conjugated linoleic acid.Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease.Computational modeling of heterogeneity and function of CD4+ T cellsLanthionine synthetase component C-like protein 2: a new drug target for inflammatory diseases and diabetes.Helicobacter pylori colonization ameliorates glucose homeostasis in mice through a PPAR γ-dependent mechanism.Modeling the Regulatory Mechanisms by Which NLRX1 Modulates Innate Immune Responses to Helicobacter pylori InfectionTreatment of Obesity-Related Complications with Novel Classes of Naturally Occurring PPAR Agonists
P50
Q21136185-D0D775BD-24F5-4D02-9E81-1138BFBE21F0Q24634256-C0494038-39F9-4451-9F0A-3F42E86A8827Q26766623-2179A453-F84E-446C-A0A9-49E733A9CBAFQ27028202-28CA8D57-248C-4292-B024-4C38AD04666CQ28476741-80BE8292-56A9-47C0-9B57-EA4CDACE84C8Q28482251-66FDD975-EBD6-4564-BCF1-65EB8695D444Q28551839-19FA35D0-0B87-400D-9D3E-0C547F0FBBB1Q28607856-C013B724-E68B-417D-BB60-D2BE2B76238EQ28730618-CFC6045F-5176-499F-B123-5D2A32D90CCEQ30301156-3F6977A6-472C-4B1A-B682-0635A04CB9EAQ30408277-6A2A318C-1DF7-49A2-A3E5-C2509672B312Q30412831-123E2048-268B-4F35-9F2A-69235E24D229Q30416570-822790EB-A842-4D07-834D-32CEDBD4F706Q30422017-2A8DA0EB-5461-44A2-B156-43C7759A71F0Q30424551-D324C50E-4707-4D61-A6DF-1D2B547B5786Q33343284-C1E94435-4111-483B-9124-36EEF6CA0206Q33502225-5525E28E-248A-45B0-A99D-48221CAC8CCFQ33524893-FAC7F6DA-2BFB-452C-9318-1F40FCEC615FQ33565689-6030D546-62C1-4E35-AF68-71D72B85CD80Q33590792-8A337780-27F8-4534-833D-430DFDF411DBQ33600282-6F7E2EF7-2006-45D9-AD01-7DB7924007F9Q33652897-CE188A9E-39AF-4E87-9FB8-E70A11CF0A67Q33717516-C1F026C9-A06F-4E16-AEFF-62134EF85C15Q33790397-C108E371-EBEF-4A1B-A128-5B5A15E7E2EBQ33901041-C970BDD0-8157-498A-B1ED-7A566DF3BA87Q33925358-97D93FE5-D488-40FF-A832-0E93DAC97966Q33937727-4E5F6030-C555-43BD-A075-E167DB8FC28BQ33952480-8281F75A-1928-4327-B857-8F3CECBF7B62Q33993882-317725C5-62C4-4E39-A229-6424FFFB7223Q33995331-E937037D-FA75-4781-8C86-6FF0D5131F54Q34136969-617C664C-EF57-45FF-B741-2EEB78DC1868Q34170678-CA6686D3-E81D-48A4-A3AB-08839358661EQ34266440-6D41778D-F33A-4807-9F6D-339C4CF582B4Q34322573-52223D63-077D-4FCD-8491-5603C66803A8Q34347638-AF6E4CA4-8C4E-4BFA-833E-FCD586BE35ADQ34391413-8BB2C1A4-CDA5-4F5F-8BEA-9994EC2FF2F3Q34410039-3B15E8C7-5C25-4350-9427-78837C75517EQ34483009-21F8CC43-68B2-4220-BC46-A9C891201E94Q34494038-56140EEE-B618-4E1C-BFAE-E607C5266DD5Q34495522-6364E73A-7967-4E64-9019-7C35EB661434
P50
name
Josep Bassaganya-Riera
@ast
Josep Bassaganya-Riera
@en
Josep Bassaganya-Riera
@es
Josep Bassaganya-Riera
@nl
type
label
Josep Bassaganya-Riera
@ast
Josep Bassaganya-Riera
@en
Josep Bassaganya-Riera
@es
Josep Bassaganya-Riera
@nl
prefLabel
Josep Bassaganya-Riera
@ast
Josep Bassaganya-Riera
@en
Josep Bassaganya-Riera
@es
Josep Bassaganya-Riera
@nl